Multiple Myeloma Refractory: Clinical Trials

2 trials for Multiple Myeloma Refractory, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 withdrawn. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Recruiting 1, Withdrawn 1

Follow Multiple Myeloma Refractory: new trials by email Literature Review of Multiple Myeloma Refractory trials Research Report on Multiple Myeloma Refractory

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma
BCMA/GPRC5D CAR-T - Multiple Myeloma Refractory
Early Phase 1WithdrawnGuangzhou Bio-gene Technology Co., Ltd2025-10-102026-05-28
A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)
Soursop tea - AML (Acute Myeloid Leukemia), Multiple Myeloma Refractory
Early Phase 1RecruitingRoger Strair202025-06-302026-08-18

Narrower conditions

Leukemia, Myeloid, Acute (1)  ·  Recurrence (1)

Broader conditions

Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

Guangzhou Bio-gene Technology Co., Ltd (1)  ·  Roger Strair (1)

Countries

United States (1)

Top investigators

Roger Strair, MD (1)